When did Thomson Reuters merger?
April 17, 2008
Thomson acquisition of Reuters The Thomson Corporation acquired Reuters Group plc to form Thomson Reuters on April 17, 2008. Thomson Reuters operated under a dual-listed company (“DLC”) structure and had two parent companies, both of which were publicly listed — Thomson Reuters Corporation and Thomson Reuters plc.
Who bought Thomson Reuters?
Onex Corporation
Sale of Intellectual Property & Science business Strengthening our focus on operating at the intersection of global commerce and regulation, Thomson Reuters announces the sale of our Intellectual Property & Science business unit to Onex Corporation and Baring Private Equity Asia for $3.55 billion.
Does Refinitiv own Thomson Reuters?
Refinitiv is 45%-owned by Reuters News’ parent Thomson Reuters. Thomson Reuters sold the majority of the business in 2018 to a consortium led by private equity giant Blackstone in a deal that valued the data provider at around $20 billion.
Who is the CEO of Reuters?
Steve Hasker (Mar 15, 2020–)
Stephen J. Adler (May 1, 2015–)
Reuters/CEO
Does Blackstone own Refinitiv?
Refinitiv is Thomson Reuters former Financial & Risk business, a majority interest in which was sold to Blackstone’s consortium in October 2018. Thomson Reuters and Blackstone’s consortium subsequently agreed to sell Refinitiv to LSEG in August 2019.
Is Reuters part of Refinitiv?
Refinitiv was part of Thomson Reuters until private equity firm Blackstone Group Inc (BX. N) acquired a majority stake in it in 2018. Blackstone and Thomson Reuters subsequently sold Refinitiv to the LSE, closing the deal in January this year.
Is james c Smith CEO of Reuters?
James C. After serving as CEO of Thomson Reuters’ professional division, Thomson Reuters named him COO in 2011 and CEO in January 2012. In February 2020, Steve Hasker succeeded Smith as President and CEO of Thomson Reuters.
Does james c Smith work for Reuters?
Thomson Reuters Foundation Chairman is also board member at Pfizer. Jim Smith, the Former President and CEO of Thomson Reuters and now the current Chairman of the Thomson Reuters Foundation, the corporate arm of the company, also sits as a board member at Pfizer – except under the name James Smith.